JPH03280948A - Compound artificial blood vessel - Google Patents

Compound artificial blood vessel

Info

Publication number
JPH03280948A
JPH03280948A JP2082055A JP8205590A JPH03280948A JP H03280948 A JPH03280948 A JP H03280948A JP 2082055 A JP2082055 A JP 2082055A JP 8205590 A JP8205590 A JP 8205590A JP H03280948 A JPH03280948 A JP H03280948A
Authority
JP
Japan
Prior art keywords
artificial blood
collagen
blood vessel
heparin
bubble point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2082055A
Other languages
Japanese (ja)
Inventor
Shosuke Yamanouchi
昭介 山之内
Yasuhiro Okuda
泰弘 奥田
Shinichi Kanazawa
進一 金澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JINKOU KETSUKAN GIJUTSU KENKYU CENTER KK
Original Assignee
JINKOU KETSUKAN GIJUTSU KENKYU CENTER KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JINKOU KETSUKAN GIJUTSU KENKYU CENTER KK filed Critical JINKOU KETSUKAN GIJUTSU KENKYU CENTER KK
Priority to JP2082055A priority Critical patent/JPH03280948A/en
Publication of JPH03280948A publication Critical patent/JPH03280948A/en
Pending legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

PURPOSE:To quickly form a vascular endothelial cell so as to promote also infiltration of a capillary vessel by adjusting a bubble point to a specific range, in the case of a compound artificial blood vessel whose pipe wall is formed of compound material of porous poly ethylene tetrafluoride, collagen or thermo degenerated collagen and heparin. CONSTITUTION:A compound artificial blood vessel is formed of a wall of porous polyethylene tetrafluoride 1 and provided with many holes 2. A collagen layer 3 mixed with heparin is formed in the wall of the hole 2. The collagen layer 3 is formed so as to prevent the hole 2 from being closed, and an adhering amount of the collagen layer is adjusted so that a bubble point obtains 0.1 to 0.01kg/cm<2>.

Description

【発明の詳細な説明】 産業上の利用分野 本発明は、大動脈、末梢動脈、心臓冠状動脈などに適用
する人工血管に関するものである。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to an artificial blood vessel that is applied to the aorta, peripheral arteries, coronary arteries, and the like.

従来の技術 多孔質ポリ四フッ化エチレンを用いた人工血管は現在広
く代用血管として実用されている。
BACKGROUND OF THE INVENTION Artificial blood vessels using porous polytetrafluoroethylene are currently widely used as blood vessel substitutes.

該人工血管の孔径は繊維長で記述されることが多(、現
在実用化されている多孔質ポリ四フッ化エチレンチ二−
ブの繊維長は17〜20μである(芦沢ら、人工臓器、
9(1)、98(1980))である。生体由来材料と
組み合せた人工血管の研究例では50μ〜100μのも
のがある(田村ら、人工臓器、1旦(3)、1500(
1987)及びアレン(Alien)ら、ジャーナル・
オブ・サージカル・リサーチ(J、Surg、Res、
)36(1)、80(1984))。
The pore diameter of the artificial blood vessel is often described in terms of fiber length (porous polytetrafluoroethylene china, which is currently in practical use).
The fiber length of the fiber is 17-20μ (Ashizawa et al., Artificial organs,
9(1), 98 (1980)). Research examples of artificial blood vessels combined with bio-derived materials include those with a diameter of 50μ to 100μ (Tamura et al., Artificial Organs, 1dan (3), 1500).
1987) and Alien et al., Journal
of Surgical Research (J, Surg, Res.
) 36(1), 80 (1984)).

一方、多孔質ポリ四フッ化エチレン等の多孔質ポリマー
チューブにコラーゲン、ヘパリンを組合せた複合人工血
管としては、■多孔質四フッ化エチレンチューブの内壁
に、ヘパリン混合コラーゲン層及びコラーゲン層を順次
形成した3層からなる人工血管、■多孔質ポリマーチュ
ーブの孔部にヘパリンを含浸し、コラーゲン層を多孔質
チューブの内壁面に形成した人工血管、■四級アンモニ
ウム化合物をバインダーとしてコラーゲンにヘパリンを
イオン結合して多孔質ポリマーチニーブの内壁面に積層
した人工血管などが知られている。
On the other hand, as a composite artificial blood vessel that combines collagen and heparin with a porous polymer tube such as porous polytetrafluoroethylene, ■ a heparin-mixed collagen layer and a collagen layer are sequentially formed on the inner wall of a porous polytetrafluoroethylene tube. Artificial blood vessel consisting of three layers: ■ Artificial blood vessel in which the pores of a porous polymer tube are impregnated with heparin and a collagen layer is formed on the inner wall of the porous tube, ■ Heparin is ionized into collagen using a quaternary ammonium compound as a binder. Artificial blood vessels are known that are bonded and laminated on the inner wall surface of a porous polymer chinive.

発明が解決しようとする課題 多孔質ポリ四フッ化エチレンチニーブを用いた人工血管
は、単独で実用化されているほか、上記のように生体材
料と複合化した複合人工血管として研究がすすめられて
いる。前者では、多孔質Hり四フッ化エチレンと生体組
織との親和性が低(ために組織治癒性(細胞侵入性)が
悪いことが欠?である。又後者は前者の欠点をおぎなう
ことを目的として研究されているものであるが、必ずし
も欠点が改良されているわけてはない。この原因につい
て鋭意研究した結果、該複合人工血管にお(て、複合化
後の孔径が小さすぎると、生体の細艶や毛細血管が侵入
できず、組織治癒性は改善さtないことが明らかになっ
た。
Problems to be Solved by the Invention Artificial blood vessels using porous polytetrafluoroethylene tinib have been put into practical use alone, and research is also progressing into composite artificial blood vessels that are combined with biomaterials as described above. ing. The former has the disadvantage of poor tissue healing properties (cell penetration) due to the low affinity between porous H-tetrafluoroethylene and living tissues.The latter also overcomes the drawbacks of the former. However, the drawbacks have not necessarily been improved.As a result of intensive research into the cause of this problem, we found that if the pore diameter of the composite artificial blood vessel is too small, It became clear that the thin skin and capillaries of the living body could not penetrate, and tissue healing properties were not improved.

課題を解決するための手段 本発明は、多孔質ポリ四フッ化エチレンとコラーゲン又
は熱変性コラーゲンとヘパリンとの複合物を管壁とする
複合人工血管に於て、バブルポイントが0.01〜0.
1に9/cx’であることを特徴とする複合人工血管を
提供するものである。
Means for Solving the Problems The present invention provides a composite artificial blood vessel whose vessel wall is a composite of porous polytetrafluoroethylene and collagen or heat-denatured collagen and heparin, which has a bubble point of 0.01 to 0. ..
The present invention provides a composite artificial blood vessel characterized by a ratio of 1 to 9/cx'.

ここでバブルポイントとは、多孔質チューブをイソプロ
ピルアルコールに含浸し、管壁の孔内をインプロピルア
ルコールで充満した後、チューブ内側より空気圧をかけ
たときに、初めて気泡が出てくる時の圧力を言う。
Here, the bubble point is the pressure at which air bubbles first appear when a porous tube is impregnated with isopropyl alcohol, the pores in the tube wall are filled with inpropyl alcohol, and then air pressure is applied from inside the tube. say.

この時、次式が成立することが知られている。At this time, it is known that the following equation holds.

P、バブルポイント δ:イソブロビルアルコールの表面張力θ、チューブと
イソプロピルアルコールの接触角 d:孔の直径 圧力Pは孔の直径dに反比例するので、直径の最も大き
な孔から最初の気泡か出る。これにより孔直径が求まる
P, bubble point δ: surface tension of isobrobyl alcohol θ, contact angle between the tube and isopropyl alcohol d: pore diameter Since pressure P is inversely proportional to pore diameter d, the first bubble comes out from the pore with the largest diameter. This determines the hole diameter.

第1図は人工血管の円周方向の断面図であり、第2図は
その縦断面図である。人工血管は、多孔質ポリ四フッ化
エチレン1の壁から成り、多数の孔2を有する。箪2図
は孔部分を拡大した図であるが、ヘパリンを混合したコ
ラーゲン層3が孔の壁に形成されている。本発明におい
ては、コラーゲン層は孔を閉塞しないよう形成されてお
り、その付着量はバブルポイントが0.1〜0.01k
y/c11!1となるように調節されている。
FIG. 1 is a circumferential sectional view of the artificial blood vessel, and FIG. 2 is a longitudinal sectional view thereof. The artificial blood vessel consists of a wall of porous polytetrafluoroethylene 1 and has a large number of pores 2. Figure 2 is an enlarged view of the hole, and a collagen layer 3 mixed with heparin is formed on the wall of the hole. In the present invention, the collagen layer is formed so as not to block the pores, and the amount of collagen layer attached is such that the bubble point is 0.1 to 0.01k.
It is adjusted so that y/c11!1.

第3図に従来技術の複合人工血管の縦断面図を示す。こ
の複合人工血管ではが、ヘパリンを混合したコラーゲン
が孔部に多量に充填されており、孔は閉塞されている。
FIG. 3 shows a longitudinal sectional view of a conventional composite artificial blood vessel. In this composite artificial blood vessel, the pores are filled with a large amount of collagen mixed with heparin, and the pores are occluded.

本発明においては、バブルポイントが0.1〜0 、0
1 kg/ cz’となるように、ヘパリンを混合分散
したコラーゲンを多孔質ポリ四フッ化エチレン孔部に、
第2図のように孔が閉塞されないようにコートする。第
3図のように孔を完全にふさぐと以下述べるように本発
明の効果を発揮しない。
In the present invention, the bubble point is 0.1 to 0,0
Collagen mixed and dispersed with heparin was added to the pores of porous polytetrafluoroethylene at a concentration of 1 kg/cz'.
Coat the holes so that they are not blocked as shown in Figure 2. If the hole is completely blocked as shown in FIG. 3, the effects of the present invention will not be exhibited as described below.

コラーゲン分子は三本ヘリックス構造をとっているため
に嵩高く、しかも水溶液は不均質で高粘度である。この
ためコラーゲン分子を多孔質ポリ四フッ化エチレン孔部
に、孔を閉塞しないように薄く均一にコートすることは
困難である。このようにコートするためには、熱変性し
たコラーゲンを用いることが望ましい。
Collagen molecules have a three-helix structure and are bulky, and their aqueous solutions are heterogeneous and highly viscous. For this reason, it is difficult to thinly and uniformly coat the porous polytetrafluoroethylene pores with collagen molecules without clogging the pores. For such coating, it is desirable to use heat-denatured collagen.

すなわち、第3図のように孔を完全に閉塞すると、バブ
ルポイントがLkf/ct、”以上となり、多孔質四フ
ッ化エチレンチューブ内壁上での内皮細胞形成が遅くな
り、しかも毛細血管の侵入も遅くなる。
That is, when the pores are completely occluded as shown in Fig. 3, the bubble point becomes more than Lkf/ct, which slows the formation of endothelial cells on the inner wall of the porous tetrafluoroethylene tube, and also prevents capillary invasion. Become slow.

一方、生体材料を複合化後にバブルポイントが0 、0
1 kg7 cm*未満である複合人工血管では、移植
時の漏血が激しいため、人工血管として使用することが
困難である。この対策として、血液によるプレクロッテ
ィング操作等を行うことが考えられるが、この操作によ
って多孔質ポリ四フッ化エチレンチューブの孔部は塞が
れてしまう。
On the other hand, after compositing the biomaterial, the bubble point is 0,0
Composite artificial blood vessels weighing less than 1 kg7 cm* are difficult to use as artificial blood vessels because of severe blood leakage during transplantation. As a countermeasure to this problem, it is possible to perform a pre-clotting operation using blood, but this operation would close the pores of the porous polytetrafluoroethylene tube.

本発明に従って、バブルポイントを上記の範囲に調節し
てヘパリンを混合分散したコラーゲンを多孔質ポリ四フ
ッ化エチレン孔部にコートすると、内皮細胞の形成が速
くなり、しかも毛細血管の侵入も速くなる。
According to the present invention, when the bubble point is adjusted to the above range and collagen mixed and dispersed with heparin is coated on the porous polytetrafluoroethylene pores, the formation of endothelial cells is accelerated, and the invasion of capillaries is also accelerated. .

ヘパリンを混合分散したコラーゲン層の形成は次の実施
例に記載したようにして行う。
The formation of a collagen layer mixed and dispersed with heparin is carried out as described in the following example.

実施例 以下、実施例及び比較例を示し、本発明を具体的に説明
する。
EXAMPLES Hereinafter, the present invention will be specifically explained by showing examples and comparative examples.

実施例1〜4及び比較例1〜4 3種の多孔質ポリ四フッ化エチレンチューブ(内径2x
x、外径3xx、気孔率約75%、バブルポイント0.
08.0.06または0.02に9/c貢りを牛けん由
来コラーゲン熱変性物0.003%水溶液に浸漬したの
ち乾燥した。この操作を6回くり返した。又バブルポイ
ント0 、02 kg/ cxtのチューブに0.01
%の同上液を用い、浸漬乾燥操作を6回行った。これら
4種類のコラーゲン複合化チニーブをゲルタールアルデ
ヒドで架橋したのち、10%へ・す;ン水溶液に含浸し
、乾燥させた(実施例1〜4)。
Examples 1 to 4 and Comparative Examples 1 to 4 Three types of porous polytetrafluoroethylene tubes (inner diameter 2x
x, outer diameter 3xx, porosity approximately 75%, bubble point 0.
On 0.08.06 or 0.02, a 9/c strain was immersed in a 0.003% aqueous solution of thermally denatured beef-based collagen, and then dried. This operation was repeated six times. Also, the bubble point is 0.01 for a tube of 0.02 kg/cxt.
% of the above solution, the immersion drying operation was performed six times. These four types of collagen composite tinibs were cross-linked with gel taraldehyde, then impregnated with a 10% aqueous solution of water and dried (Examples 1 to 4).

4種類の複合チューブ(実施例1〜4)及び3種類の未
処理チューブ(比較例1〜3)それぞれ3Bをウサギの
頚動脈へ移植した。
Four types of composite tubes (Examples 1 to 4) and three types of untreated tubes (Comparative Examples 1 to 3) 3B were each implanted into the carotid artery of a rabbit.

一方、0 、06 kg7 C1+’のバブルポイント
をもつチューブを0.3%コラーゲン水溶液に浸漬し、
乾燥後ゲルタールアルデヒドで架橋しヘパリン水溶液に
浸漬した。同様にウサギ顆動脈に移植した(比較例4)
On the other hand, a tube with a bubble point of 0.06 kg7 C1+' was immersed in a 0.3% collagen aqueous solution.
After drying, it was crosslinked with geltaraldehyde and immersed in an aqueous heparin solution. It was similarly transplanted into the rabbit condylar artery (Comparative Example 4)
.

移植2週間後、内皮細胞被覆率及び毛細血管の侵入数を
カウント評価した。結果を表−1に示す。
Two weeks after transplantation, the endothelial cell coverage and the number of capillary invasions were counted and evaluated. The results are shown in Table-1.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、複合人工血管の円周方向の断面図、第2図は
、第1図の複合人工血管の縦断面図、第3図は従来技術
の複合人工血管の円周方向の断面図であり孔部は生体由
来材料で充満している。 1・・・多孔質口フッ化エチレンチューブ、2・・・孔
、3・・・ヘパリン混合コラーゲン層
FIG. 1 is a circumferential cross-sectional view of a composite artificial blood vessel, FIG. 2 is a longitudinal cross-sectional view of the composite artificial blood vessel of FIG. 1, and FIG. 3 is a circumferential cross-sectional view of a conventional composite artificial blood vessel. The pores are filled with bio-derived material. 1...Porous fluorinated ethylene tube, 2...pores, 3...heparin mixed collagen layer

Claims (1)

【特許請求の範囲】[Claims] 1.多孔質ポリ四フッ化エチレンとコラーゲン又は熱変
性コラーゲンとヘパリンとの複合物を管壁とする複合人
工血管に於て、バブルポイントが0.01〜0.1kg
/cm^2であることを特徴とする複合人工血管。
1. In a composite artificial blood vessel whose vessel wall is a composite of porous polytetrafluoroethylene and collagen or heat-denatured collagen and heparin, the bubble point is 0.01 to 0.1 kg.
/cm^2.
JP2082055A 1990-03-29 1990-03-29 Compound artificial blood vessel Pending JPH03280948A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2082055A JPH03280948A (en) 1990-03-29 1990-03-29 Compound artificial blood vessel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2082055A JPH03280948A (en) 1990-03-29 1990-03-29 Compound artificial blood vessel

Publications (1)

Publication Number Publication Date
JPH03280948A true JPH03280948A (en) 1991-12-11

Family

ID=13763832

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2082055A Pending JPH03280948A (en) 1990-03-29 1990-03-29 Compound artificial blood vessel

Country Status (1)

Country Link
JP (1) JPH03280948A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6053939A (en) * 1996-02-15 2000-04-25 Vascular Graft Research Center Co., Ltd. Artificial blood vessel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6053939A (en) * 1996-02-15 2000-04-25 Vascular Graft Research Center Co., Ltd. Artificial blood vessel

Similar Documents

Publication Publication Date Title
US5632776A (en) Implantation materials
US4229838A (en) Vascular prosthesis having a composite structure
EP0352199B1 (en) Hydrophilic material and method of manufacturing the same
US4911713A (en) Method of making vascular prosthesis by perfusion
EP1173237B1 (en) Expanded polytetrafluoroethylene vascular graft with coating
US5716660A (en) Tubular polytetrafluoroethylene implantable prostheses
EP0265906B1 (en) Wound dressing
US5578073A (en) Thromboresistant surface treatment for biomaterials
JPS63119755A (en) Artificial blood vessel and its production
US4803078A (en) Wound dressing
HUT71525A (en) Medical material and process for producing the same
JPH0767895A (en) Antibacterial artificial blood vessel and antibacterial surgical suture
JPS62258666A (en) Cross-linked gelatin-impregnated artificial blood vessel and its manufacturing method
JP5638138B2 (en) Hollow fiber membrane blood purification device
US6833153B1 (en) Hemocompatible coatings on hydrophobic porous polymers
US20080125857A1 (en) Hemocompatible polymers on hydrophobic porous polymers
EP0512122A1 (en) Implant material
JPH03280948A (en) Compound artificial blood vessel
US6350462B1 (en) Hollow porous ceramic carrier for embedding in patient for sustained medicament release and method of preparation thereof
CN110025830B (en) A slow-release antibacterial artificial dermis model and its construction method
JP3398415B2 (en) Antithrombotic catheter
JPH05269196A (en) Multilayered artificial blood vessel
JPS61263448A (en) Blood vessel prosthesis
JPS612743A (en) Porous membrane
Sinha et al. Blood-cellulosics interactions